Cipla (CIPLA) — Announcement

📢 Key Event
Cipla reported highest-ever Q1 FY27 revenue of INR 7,119 crores

🔄 What Changed
EBITDA margin declined to 16.7% from 25.6% YoY

💡 Investor Takeaway
Shareholders should note PAT declined 39% YoY despite revenue growth due to margin compression and tax impacts.

⚠️ Risks
Higher tax expenses and margin pressure

Cipla reported its highest-ever Q1 FY27 revenue of INR 7,119 crores, up 2.4% YoY, driven by strong performance across One India, North America, and One Africa segments. EBITDA margin expanded to 16.7% from 25.6% in Q1 FY26, while PAT declined 39% YoY to INR 789 crores due to higher expenses and tax impacts. The presentation highlighted new product launches, including gVentolin in the U.S. market and AB-rated generic Ventolin, alongside ESG progress like 57% renewable electricity use in India. Investor relations confirmed the filing as an official investor presentation under SEBI regulations, with no forward guidance provided.

📄 View Original Announcement (PDF)

📊 Stock Analysis — CIPLA ✨ Ask AI About This

About Cipla Limited (CIPLA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,15,682.55 Cr P/E: 25.4 ROE: 14.6% ROCE: 19.4%

View full CIPLA stock details →

📡 Get AI alerts when CIPLA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CIPLA — Free

💡 Ask AI about this filing

"How does Cipla's 16.7% EBITDA margin compare to peers?" "What is the revenue contribution from new gVentolin launches?" "When will PAT margin improve after current tax pressures?"

Ask AI Free →

📊 More CIPLA filings

See all CIPLA filings →

🔥 Also filed on 23 July 2026

INFY Infosys Limited Financial Results PNBHOUSING PNB Housing Finance Limited Annual Report BPCL Bharat Petroleum Corporation Limited Financial Results CHAMBLFERT Chambal Fertilizers & Chemicals Limited Financial Results SONACOMS Sona BLW Precision Forgings Limited Financial Results TRU TruCap Finance Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CIPLA files new disclosures

Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.